FOI release

Information about Sipavibart/Kavigale

This request was refused in full, so we didn't provide the information the requester asked for. This may include information where we can neither confirm nor deny that we hold it.

Case reference FOI2025/00468

Received 14 May 2025

Published 23 June 2025

Request

AstraZeneca have confirmed that Sipavibart/Kavigale is under assessment by the MHRA. Please can you provide details to: - how far along the assessment process the department is - how many emails has MHRA received regarding sipavibart - when that process is due to conclude

Response

see attached

Documents

• FOI2025_00468 redacted for publication.pdf (179.1 KB)

This is Medicines and Healthcare products Regulatory Agency's response to a freedom of information (FOI) or environmental information regulations (EIR) request.

You can browse our other responses or make a new FOI request.